[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Dr. Jonathan Licht, MD on high-risk 4;14 myeloma and MMSET's function and future targets

Dr. Jonathan Licht, MD on high-risk 4;14 myeloma and MMSET's function and future targets image

Dr. Jonathan Licht, MD on high-risk 4;14 myeloma and MMSET's function and future targets

Podcast
event Apr 11, 2014 / 11:00AM MDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Learn about all myeloma happenings on the new Myeloma Crowd site: the first comprehensive site for myeloma patients and caregivers. Dr. Jonathan Licht, MD Northwestern University Robert H. Lurie Comprehensive Cancer Center Interview date: April 11, 2014

 Dr. Licht shares a deep dive into high risk myeloma with an emphasis on the 4;14 mutation that triggers the overproliferation of the MMSET gene. Dr. Licht describes how MMSET affects the cells and his work to screen 100,000 compounds against that gene to find targets that impact MMSET effectively. He describes the relationship between the MMSET and MYC genes and how MMSET promotes MYC growth. He shares how cell signaling pathway treatments, like MEK inhibitors and BRAF inhibitors are being studied to change the signaling for cancer growth for high risk and normal risk myeloma as well.    The live mPatient Myeloma Radio podcast with Dr. Jonathan Licht

Schedule & Agenda

Event panelist Dr. Jonathan Licht, MD & Jennifer Ahlstrom
11:00 AM
Discussion
Dr. Jonathan Licht, MD & Jennifer Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.